Bakhtiar Yamini to NF-kappa B
This is a "connection" page, showing publications Bakhtiar Yamini has written about NF-kappa B.
Connection Strength
2.721
-
CDK1 is up-regulated by temozolomide in an NF-?B dependent manner in glioblastoma. Sci Rep. 2021 03 11; 11(1):5665.
Score: 0.584
-
DDX39B interacts with the pattern recognition receptor pathway to inhibit NF-?B and sensitize to alkylating chemotherapy. BMC Biol. 2020 03 24; 18(1):32.
Score: 0.546
-
Temozolomide Treatment Induces lncRNA MALAT1 in an NF-?B and p53 Codependent Manner in Glioblastoma. Cancer Res. 2019 05 15; 79(10):2536-2548.
Score: 0.511
-
Nuclear factor-?B in glioblastoma: insights into regulators and targeted therapy. Neuro Oncol. 2016 Mar; 18(3):329-39.
Score: 0.403
-
DNA damage-induced cytotoxicity is mediated by the cooperative interaction of phospho-NF-?B p50 and a single nucleotide in the ?B-site. Nucleic Acids Res. 2013 Jan; 41(2):764-74.
Score: 0.329
-
Inhibition of nuclear factor-kappaB activity by temozolomide involves O6-methylguanine induced inhibition of p65 DNA binding. Cancer Res. 2007 Jul 15; 67(14):6889-98.
Score: 0.227
-
BCL3 expression promotes resistance to alkylating chemotherapy in gliomas. Sci Transl Med. 2018 07 04; 10(448).
Score: 0.121